ATE291033T1 - Therapeutische peptide - Google Patents

Therapeutische peptide

Info

Publication number
ATE291033T1
ATE291033T1 AT01946869T AT01946869T ATE291033T1 AT E291033 T1 ATE291033 T1 AT E291033T1 AT 01946869 T AT01946869 T AT 01946869T AT 01946869 T AT01946869 T AT 01946869T AT E291033 T1 ATE291033 T1 AT E291033T1
Authority
AT
Austria
Prior art keywords
type
ifn
seq
analogues
terminus
Prior art date
Application number
AT01946869T
Other languages
English (en)
Inventor
Michael Gerard Tovey
Pierre Eid
Original Assignee
Medarex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medarex Inc filed Critical Medarex Inc
Application granted granted Critical
Publication of ATE291033T1 publication Critical patent/ATE291033T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7156—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT01946869T 2000-01-25 2001-01-25 Therapeutische peptide ATE291033T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0001712.9A GB0001712D0 (en) 2000-01-25 2000-01-25 Therapeutic peptides
PCT/GB2001/000287 WO2001055215A1 (en) 2000-01-25 2001-01-25 Therapeutic peptides

Publications (1)

Publication Number Publication Date
ATE291033T1 true ATE291033T1 (de) 2005-04-15

Family

ID=9884323

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01946869T ATE291033T1 (de) 2000-01-25 2001-01-25 Therapeutische peptide

Country Status (10)

Country Link
US (2) US20040067888A1 (de)
EP (1) EP1250358B1 (de)
JP (1) JP2003525040A (de)
AT (1) ATE291033T1 (de)
AU (1) AU2865801A (de)
CA (1) CA2397267A1 (de)
DE (1) DE60109412T2 (de)
ES (1) ES2240475T3 (de)
GB (1) GB0001712D0 (de)
WO (1) WO2001055215A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
JP2007525458A (ja) * 2003-04-23 2007-09-06 メダレックス インコーポレイテッド インターフェロンα受容体−１（ＩＦＮＡＲ−１）に対するヒト化抗体
AU2004232362C1 (en) 2003-04-23 2008-05-29 E. R. Squibb & Sons, L.L.C. Compositions and methods for the therapy of inflammatory bowel disease
US7662381B2 (en) 2004-06-21 2010-02-16 Medarex, Inc. Interferon alpha receptor 1 antibodies and their uses
CN101056654A (zh) * 2004-10-07 2007-10-17 苏黎士大学 用于预防和治疗银屑病的i型干扰素阻断剂
CN101155831B (zh) * 2005-02-10 2015-08-19 贝勒研究院 抗干扰素α单克隆抗体及其使用方法
CN102083859B (zh) 2008-05-07 2014-09-17 阿哥斯医疗公司 人源化抗人干扰素-α抗体
WO2014004639A1 (en) 2012-06-26 2014-01-03 Sutro Biopharma, Inc. Modified fc proteins comprising site-specific non-natural amino acid residues, conjugates of the same, methods of their preparation and methods of their use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5889151A (en) * 1989-10-20 1999-03-30 Societe Leb-Tech Purified human alpha interferon receptor
EP0563487A1 (de) * 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoklonale Antikörper gegen den Interferonrezeptor, mit neutralisierender Aktivität gegen Typ I-Interferon

Also Published As

Publication number Publication date
GB0001712D0 (en) 2000-03-15
US20070042963A1 (en) 2007-02-22
AU2865801A (en) 2001-08-07
JP2003525040A (ja) 2003-08-26
CA2397267A1 (en) 2001-08-02
DE60109412T2 (de) 2006-04-13
EP1250358B1 (de) 2005-03-16
EP1250358A1 (de) 2002-10-23
WO2001055215A1 (en) 2001-08-02
US20040067888A1 (en) 2004-04-08
ES2240475T3 (es) 2005-10-16
DE60109412D1 (en) 2005-04-21

Similar Documents

Publication Publication Date Title
DK1531791T3 (da) Forebyggelse og begrænsning af iskæmi
DE69838143D1 (de) Antimikrobielle peptide
EP1801206A4 (de) Verfahren zur herstellung von l-arginin, l-ornithin oder l-citrullin
ATE291033T1 (de) Therapeutische peptide
EP1092727A3 (de) G-protein rezeptor
ATE474589T1 (de) Angiogene peptide und ihre verwendungen
ATE362939T1 (de) Dimere von thrombinpeptidderivaten
CY1109946T1 (el) Τροποποιημενα πεπτιδια και η χρηση τους για τη θεραπεια αυτοανοσων νοσων
WO2004087054A3 (en) Methods for modulating gastric secretion using prokineticin receptor antagonists.
ATE294816T1 (de) Neue, physiologisch aktive peptide und ihre verwendung.
ES2180781T3 (es) Nuevos ligandos del receptor opiaceo mu: agonistas y antagonistas.
WO2002066617A8 (en) Method for detecting a risk of hypertension and uses thereof
GB9416536D0 (en) Orphan receptor
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
ATE375390T1 (de) G-protein-gekoppelter rezeptor-ähnliche proteine
WO2002038607A3 (en) A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
DE60325227D1 (de)
EP1096008A3 (de) Menschlicher G-Protein-gekoppelter Rezeptor, PFI-014
AU4956901A (en) Novel human 7tm proteins and polynucleotides encoding the same
EP1094109A3 (de) Menschlicher G-Protein-gekoppelter Rezeptor, PFI-010
EP1225183A3 (de) Humaner G-Protein gekoppelter Rezeptor
WO2002092624A3 (en) G-protein coupled receptor
GB0520568D0 (en) Receptor
WO2003033536A3 (en) G-protein coupled receptor
SG170757A1 (en) Polypeptide having esterase activity and recombinant esterase and use thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties